Egg Harbor Township, NJ (PRWEB) August 28, 2017
Curexa® Pharmacy proudly announces the availability of VOSEVI™. VOSEVI™ (sofosbuvir, velpatasvir, and voxilaprevir) is a newly approved chronic Hepatitis C oral therapy.
Curexa® Pharmacy offers a full range of capabilities including retail, specialty care and compounding pharmacy services with local pick-up, local delivery and nationwide shipping options. Curexa® is excited to offer world class patient satisfaction and customer service to our patients and partnering providers.
VOSEVI™ is a fixed-dose combination of sofosbuvir, a hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitor, velpatasvir, an HCV NS5A inhibitor, and voxilaprevir, an HCV NS3/4A protease inhibitor, and is indicated for the treatment of adult patients with chronic HCV infection without cirrhosis or with compensated cirrhosis (Child-Pugh A) who have:
1. genotype 1, 2, 3, 4, 5, or 6 infection and have previously been treated with an HCV regimen containing an NS5A inhibitor.
2. genotype 1a or 3 infection and have previously been treated with an HCV regimen containing sofosbuvir without an NS5A inhibitor. - Additional benefit of VOSEVI™ over sofosbuvir/velpatasvir was not shown in adults with genotype 1b, 2, 4, 5, or 6 infection previously treated with sofosbuvir without an NS5A inhibitor.
VOSEVI™ is manufactured by Gilead Sciences, Inc. For full prescribing information, click here.
For more information about Curexa®, please visit http://www.curexa.com, or contact us at rx(at)curexa.com or 855.927.0390.
About Curexa® Pharmacy
Curexa® is committed to improving patients’ outcomes by providing optimal service and an unsurpassed level of care. By integrating clinical pharmacy care with technology and dedication to the patient, we offer an unparalleled pharmacy experience enabling a healthier tomorrow. Our goal is to optimize appropriate medication use while maximizing adherence and patient satisfaction
Curexa®, a full-service pharmacy, is accredited by ACHC and URAC for specialty pharmacy, as well as Focus Script and PCAB for compounding pharmacy. Currently licensed in 48 states, Curexa® is a national leader in providing medications to patients and healthcare professionals.
At Curexa®, we are an extension of your healthcare team. We understand the complex nature of caring for the specialty patient and we offer the required services to ensure the highest level of care. Not all pharmacies are the same. Let us prove to you how we can play an integral role in your care and patient satisfaction. Please visit our website today at http://www.curexa.com.